financetom
Business
financetom
/
Business
/
IMPACT Silver Down After Upsizing Bought Deal LIFE Private Placement for $13 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IMPACT Silver Down After Upsizing Bought Deal LIFE Private Placement for $13 Million
Sep 3, 2025 10:56 AM

01:39 PM EDT, 09/03/2025 (MT Newswires) -- IMPACT Silver ( ISVLF ) was last seen down 13% on Wednesday after it upsized a bought-deal private placement to about $13 million, up from its prior $8 million target.

The company will now sell an underwriting syndicate 36.1-million units of the company, with each priced at $0.36 and made up of a share and a two-year warrant to buy a share for $0.45.

The company also granted the underwriters an 8.3-million unit over-allotment option, exercisable up to 48 hours prior to the closing date, expected on Sept. 17.

Proceeds will be used to expand mining operations at its Guadalupe Production Centre in the states of Mexico and Guerrero, and at its Plomosas zinc-silver-lead mine and production centre in the state of Chihuahua, Mexico. Proceeds will also be used for general working capital and corporate needs.

Shares of the company were last seen down $0.05 at $0.33 on the TSX Venture Exchange.

Price: 0.33, Change: -0.05, Percent Change: -12.37

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Neurocrine's Phase 3 Trial of Valbenazine in Dyskinetic Cerebral Palsy Fails to Meet Primary, Key Secondary Endpoints
Neurocrine's Phase 3 Trial of Valbenazine in Dyskinetic Cerebral Palsy Fails to Meet Primary, Key Secondary Endpoints
Mar 10, 2026
04:36 PM EST, 12/22/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Monday its phase 3 trial assessing the efficacy, safety, and tolerability of valbenazine in pediatric and adult participants with dyskinetic cerebral palsy did not meet primary or key secondary endpoints. The primary goal of the trial was to evaluate improvement in chorea, which is a type of...
HAFNIA LIMITED: Hafnia Completes Acquisition of 13.97% of TORM
HAFNIA LIMITED: Hafnia Completes Acquisition of 13.97% of TORM
Mar 10, 2026
SINGAPORE--(BUSINESS WIRE)-- With reference to the stock exchange announcement of 18 December 2025, in which Hafnia Limited ( HAFN ) announced that all conditions precedent for completion of the share purchase agreement (the “Share Purchase Agreement”) entered into with Oaktree Capital Management, L.P. and its affiliates (together, Oaktree), have been satisfied, Hafnia ( HAFN ) is pleased to announce that...
Integra Resources Up 2% In US After Hours As Retires US$15 Million Beedie Capital Convertible Debenture
Integra Resources Up 2% In US After Hours As Retires US$15 Million Beedie Capital Convertible Debenture
Mar 10, 2026
04:36 PM EST, 12/22/2025 (MT Newswires) -- Integra Resources ( ITRG ) was at last look up 2% in US after hours trade Monday, while it has also touched a fresh 52 week high, as it announced the full conversion and repayment of the Beedie Investment convertible debenture facility. The company said it issued nearly 12.3 million common shares at...
Silicon Valley Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering
Silicon Valley Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering
Mar 10, 2026
PALO ALTO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Silicon Valley Acquisition Corp. (the “Company”) announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit on December 22, 2025. The units are expected to be listed for trading on the Nasdaq Stock Market LLC under the ticker symbol “SVAQU” beginning December 23,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved